Also trades as: 3349.T (JPX) · $vol 16M
CSMYF OTC
COSMOS Pharmaceutical Corporation
1W: +9.2%
1M: +9.2%
3M: +9.2%
YTD: -16.2%
1Y: -12.2%
3Y: -16.1%
$40.45
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$58.8B
+12.2% ▲
5Y CAGR: +16.1%
Capital Expenditures
$70.5B
-32.3% ▼
5Y CAGR: +22.0%
Free Cash Flow
-$11.7B
-1260.1% ▼
Dividends Paid
$5.9B
-19.9% ▼
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$1.7B
-136.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $33.0B | $32.8B | $24.5B | $42.4B | $32.1B |
| Depreciation & Amort. | $15.1B | $17.4B | $19.9B | $22.2B | $24.6B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$1.2B | $10.2B | $7.4B | -$8.6B | $2.7B |
| Other Non-Cash Items | -$14.8B | -$5.9B | $3.4B | -$3.6B | -$524M |
| Operating Cash Flow | $32.2B | $54.4B | $55.2B | $52.5B | $58.8B |
| — Investing Activities — | |||||
| Capital Expenditures | -$43.5B | -$46.6B | -$55.8B | -$53.3B | -$70.5B |
| Acquisitions (Net) | $1.5B | $46M | $0 | $0 | $296M |
| Investment Purchases | -$713M | -$500M | $0 | $0 | -$8.8B |
| Investment Sales | $407M | $428M | $0 | $0 | $417M |
| Other Investing | -$1.4B | -$2.5B | -$1.5B | -$2.1B | -$3.4B |
| Investing Cash Flow | -$43.7B | -$49.1B | -$57.3B | -$55.4B | -$82.0B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1.2B | $8.4B | $15.2B | $14.9B | $25.3B |
| Stock Repurchased | -$2M | $0 | $0 | -$2M | $0 |
| Dividends Paid | -$3.3B | -$3.3B | -$4.7B | -$5.0B | -$5.9B |
| Other Financing | -$1.8B | -$1.9B | -$2.0B | -$2.2B | -$1M |
| Financing Cash Flow | -$6.2B | $3.2B | $8.5B | $7.7B | $19.3B |
| Net Change in Cash | -$17.7B | $8.6B | $6.4B | $4.7B | -$1.7B |
| Cash End of Period | $37.4B | $45.9B | $52.3B | $57.0B | $61.4B |
| Free Cash Flow | -$11.3B | $7.8B | -$635M | -$859M | -$11.7B |